In-silico studies of inhibitory compounds against protease enzymes of SARS-CoV-2

In December 2019, a COVID-19 outbreak caused by SARS-CoV-2 raised worldwide health concerns. In this case, molecular docking and drug repurposing computational approaches were engaged to check the efficiency of plant-based inhibitory compounds against SARS-CoV-2 main protease enzyme and papain-like...

Descripción completa

Detalles Bibliográficos
Autores principales: Khan, Saba, Nasrullah, Hussain, Abrar, Asif, Muhammad, Sattar, Fouzia Abdul, Audhal, Fayyaz Ahmed, Qadir, Muhammad Imran, Hamdard, Muhammad Hamid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
4900
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9907915/
https://www.ncbi.nlm.nih.gov/pubmed/36820539
http://dx.doi.org/10.1097/MD.0000000000031318

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9907915/
https://www.ncbi.nlm.nih.gov/pubmed/36820539
http://dx.doi.org/10.1097/MD.0000000000031318

Ejemplares similares